Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2017-10-27 Regulatory Filings
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2017
Regulatory Filings
2017-10-27 English
Regulatory Filings 2017
Regulatory Filings Classification · 95% confidence The document is a letter from ITUS Corporation to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3. It is a correspondence related to a securities registration filing, specifically about the timing of the effectiveness of the filing. The document does not contain financial statements, audit information, or detailed report content. It is a regulatory communication about a filing process, not a report or announcement of financial results. The document length is short (1672 characters), and it is a formal request letter, which fits best under Regulatory Filings (RNS) as a general regulatory announcement and correspondence with the SEC.
2017-10-24 English
PRIMARY DOCUMENT
Director's Dealing
2017-10-23 English
Regulatory Filings 2017
Regulatory Filings Classification · 90% confidence The provided document text appears to be an encoded or binary file content (likely a PDF or similar) rather than readable text. There are no discernible keywords, regulatory references, form names, fiscal period dates, or document titles visible in the text. The document length is 15,000 characters, which is substantial, but the content is not human-readable and does not provide any clear indication of the filing type. Given the lack of identifiable information and the nature of the content, the best classification is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2017-10-23 English
FORM S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 registration statement filed with the SEC, which is used for registering securities for sale to the public. It includes details about the types of securities to be offered (common stock, preferred stock, warrants, units), the maximum aggregate offering price, and other offering-related information. It is not a financial report, earnings release, or management discussion. It is a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, so it is not an RPA or RNS. Hence, the correct classification is CAP with high confidence.
2017-10-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 2, 2017. It reports that ITUS Corporation has regained compliance with Nasdaq listing rules after previously being non-compliant due to minimum bid price requirements. The document includes a press release as an exhibit announcing the regained compliance. There are no financial statements or detailed financial data included, and the document is relatively short (3429 characters). This is a regulatory announcement about compliance status and listing, not a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance updates that do not fit other specific categories.
2017-10-03 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.